These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 8200167
21. Etiology and incidence of thrombotic and hemorrhagic disorders in Thai patients with extreme thrombocytosis. Chuncharunee S, Archararit N, Ungkanont A, Jootar S, Angchaisuksiri P, Bunyaratavej A, Rojanasthein S, Atichartakarn V. J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S95-100. PubMed ID: 10865414 [Abstract] [Full Text] [Related]
22. Thrombocytosis in children. Chiarello P, Magnolia M, Rubino M, Liguori SA, Miniero R. Minerva Pediatr; 2011 Dec; 63(6):507-13. PubMed ID: 22075805 [Abstract] [Full Text] [Related]
28. Clinicohematological study of thrombocytosis in children. Subramaniam N, Mundkur S, Kini P, Bhaskaranand N, Aroor S. ISRN Hematol; 2014 Mar; 2014():389257. PubMed ID: 25006474 [Abstract] [Full Text] [Related]
32. Thrombocytosis and microthrombocytosis: a clinical evaluation of 372 cases. Robbins G, Barnard DL. Acta Haematol; 1983 Oct; 70(3):175-82. PubMed ID: 6410644 [Abstract] [Full Text] [Related]
33. Incidence and clinical significance of reactive thrombocytosis in children aged 1 to 24 months, hospitalized for community-acquired infections. Indolfi G, Catania P, Bartolini E, Azzari C, Massai C, Poggi GM, De Martino M, Resti M. Platelets; 2008 Sep; 19(6):409-14. PubMed ID: 18925508 [Abstract] [Full Text] [Related]
36. Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile. Steurer M, Gastl G, Jedrzejczak WW, Pytlik R, Lin W, Schlögl E, Gisslinger H. Cancer; 2004 Nov 15; 101(10):2239-46. PubMed ID: 15476273 [Abstract] [Full Text] [Related]